Efficacy of vonoprazan for initial and maintenance therapy in reflux esophagitis, nonerosive esophagitis, and proton pump inhibitor-resistant gastroesophageal reflux disease

Proton pump inhibitors (PPIs) have been the first line treatment for gastroesophageal reflux disease (GERD). The aim of this study was to evaluate the efficacy of vonoprazan (VPZ), a potassium-competitive acid blocker for reflux esophagitis (RE), nonerosive reflux disease (NERD), and PPI-resistant G...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Medicine (Baltimore)
Asıl Yazarlar: Gotoh, Yasuhiko, Ishibashi, Emiko, Honda, Shunichiro, Nakaya, Tomohisa, Noguchi, Chishio, Kagawa, Koichi, Murakami, Kazunari
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Wolters Kluwer Health 2020
Konular:
4500
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7440130/
https://ncbi.nlm.nih.gov/pubmed/32176102
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000019520
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller